|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
275 a.a.
|
 |
|
|
|
|
|
|
|
100 a.a.
|
 |
|
|
|
|
|
|
|
193 a.a.
|
 |
|
|
|
|
|
|
|
243 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Directed evolution of human t-cell receptor cdr2 residues by phage display dramatically enhances affinity for cognate peptide-mhc without apparent cross-reactivity
|
|
Structure:
|
 |
Hla class i histocompatibility antigen. Chain: a. Fragment: extracellular domains alpha 1, alpha2 and alpha3, residues 25-299. Synonym: mhc class i antigen a 2. Engineered: yes. Beta-2-microglobulin. Chain: b. Fragment: beta-2 microglobulin, residues 21-119.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Synthetic: yes. Other_details: this sequence occurs naturally in homo sapiens (humans).
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.169
|
R-free:
|
0.231
|
|
|
Authors:
|
 |
P.J.Rizkallah,B.K.Jakobsen,S.M.Dunn,M.Sami
|
Key ref:
|
 |
S.M.Dunn
et al.
(2006).
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
Protein Sci,
15,
710-721.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Nov-05
|
Release date:
|
25-Apr-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04439
(1A03_HUMAN) -
HLA class I histocompatibility antigen, A alpha chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
365 a.a.
275 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P61769
(B2MG_HUMAN) -
Beta-2-microglobulin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
119 a.a.
100 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Sci
15:710-721
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
|
|
S.M.Dunn,
P.J.Rizkallah,
E.Baston,
T.Mahon,
B.Cameron,
R.Moysey,
F.Gao,
M.Sami,
J.Boulter,
Y.Li,
B.K.Jakobsen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The mammalian alpha/beta T cell receptor (TCR) repertoire plays a pivotal role
in adaptive immunity by recognizing short, processed, peptide antigens bound in
the context of a highly diverse family of cell-surface major histocompatibility
complexes (pMHCs). Despite the extensive TCR-MHC interaction surface,
peptide-independent cross-reactivity of native TCRs is generally avoided through
cell-mediated selection of molecules with low inherent affinity for MHC. Here we
show that, contrary to expectations, the germ line-encoded complementarity
determining regions (CDRs) of human TCRs, namely the CDR2s, which appear to
contact only the MHC surface and not the bound peptide, can be engineered to
yield soluble low nanomolar affinity ligands that retain a surprisingly high
degree of specificity for the cognate pMHC target. Structural investigation of
one such CDR2 mutant implicates shape complementarity of the mutant CDR2 contact
interfaces as being a key determinant of the increased affinity. Our results
suggest that manipulation of germ line CDR2 loops may provide a useful route to
the production of high-affinity TCRs with therapeutic and diagnostic potential.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Structural depiction of the CDR2 mutant interactions in the
c49c50 --pMHC complex. (A) The CDR2[beta] loop mutations (GAGI
to SVGM). The 2BNR model is depicted in red; the c49c50 TCR is
colored by atom type, mostly green; the c49c50 MHC is mostly
red. Dotted lines indicate contacts between mutated side chains
and MHC residues. (B) The CDR2[alpha] loop mutations (QSS to
PFW): Q155 of the MHC is pushed deeper into the pocket by the
close approach of F51, while W52 forces a tighter packing of the
CDR1[alpha] Y30 against W5 of the peptide. The 2BNR MHC is red
and the c49c50 TCRa is mostly orange. The figures were prepared
using PyMOL (DeLano 2002).
|
 |
Figure 4.
Electron density contoured at 2[sigma] around the identified
metal site (black) in the peptide binding groove of the MHC.
Some of the approach contacts are indicated. MHC residues are
blue. The bound peptide is yellow. TCR [alpha] and [beta] chain
residues are orange and green, respectively. Water molecules are
displayed as purple spheres. The figure was generated using
PyMOL (DeLano 2002).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(2006,
15,
710-721)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.H.Aggen,
A.S.Chervin,
F.K.Insaidoo,
K.H.Piepenbrink,
B.M.Baker,
and
D.M.Kranz
(2011).
Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.
|
| |
Protein Eng Des Sel,
24,
361-372.
|
 |
|
|
|
|
 |
J.M.Khan,
and
S.Ranganathan
(2011).
Understanding TR Binding to pMHC Complexes: How Does a TR Scan Many pMHC Complexes yet Preferentially Bind to One.
|
| |
PLoS One,
6,
e17194.
|
 |
|
|
|
|
 |
R.K.Moysey,
Y.Li,
S.J.Paston,
E.E.Baston,
M.S.Sami,
B.J.Cameron,
J.Gavarret,
P.Todorov,
A.Vuidepot,
S.M.Dunn,
N.J.Pumphrey,
K.J.Adams,
F.Yuan,
R.E.Dennis,
D.H.Sutton,
A.D.Johnson,
J.E.Brewer,
R.Ashfield,
N.M.Lissin,
and
B.K.Jakobsen
(2010).
High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.
|
| |
Protein Cell,
1,
1118-1127.
|
 |
|
|
|
|
 |
V.Zoete,
M.B.Irving,
and
O.Michielin
(2010).
MM-GBSA binding free energy decomposition and T cell receptor engineering.
|
| |
J Mol Recognit,
23,
142-152.
|
 |
|
|
|
|
 |
J.N.Haidar,
B.Pierce,
Y.Yu,
W.Tong,
M.Li,
and
Z.Weng
(2009).
Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC.
|
| |
Proteins,
74,
948-960.
|
 |
|
|
|
|
 |
N.Anikeeva,
T.Mareeva,
W.Liu,
and
Y.Sykulev
(2009).
Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?
|
| |
Clin Immunol,
130,
98.
|
 |
|
|
|
|
 |
S.A.Richman,
D.H.Aggen,
M.L.Dossett,
D.L.Donermeyer,
P.M.Allen,
P.D.Greenberg,
and
D.M.Kranz
(2009).
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.
|
| |
Mol Immunol,
46,
902-916.
|
 |
|
|
|
|
 |
A.Varela-Rohena,
C.Carpenito,
E.E.Perez,
M.Richardson,
R.V.Parry,
M.Milone,
J.Scholler,
X.Hao,
A.Mexas,
R.G.Carroll,
C.H.June,
and
J.L.Riley
(2008).
Genetic engineering of T cells for adoptive immunotherapy.
|
| |
Immunol Res,
42,
166-181.
|
 |
|
|
|
|
 |
J.D.Abad,
C.Wrzensinski,
W.Overwijk,
M.A.De Witte,
A.Jorritsma,
C.Hsu,
L.Gattinoni,
C.J.Cohen,
C.M.Paulos,
D.C.Palmer,
J.B.Haanen,
T.N.Schumacher,
S.A.Rosenberg,
N.P.Restifo,
and
R.A.Morgan
(2008).
T-cell receptor gene therapy of established tumors in a murine melanoma model.
|
| |
J Immunother,
31,
1-6.
|
 |
|
|
|
|
 |
L.L.Jones,
L.A.Colf,
A.J.Bankovich,
J.D.Stone,
Y.G.Gao,
C.M.Chan,
R.H.Huang,
K.C.Garcia,
and
D.M.Kranz
(2008).
Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.
|
| |
Biochemistry,
47,
12398-12408.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.F.Robbins,
Y.F.Li,
M.El-Gamil,
Y.Zhao,
J.A.Wargo,
Z.Zheng,
H.Xu,
R.A.Morgan,
S.A.Feldman,
L.A.Johnson,
A.D.Bennett,
S.M.Dunn,
T.M.Mahon,
B.K.Jakobsen,
and
S.A.Rosenberg
(2008).
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.
|
| |
J Immunol,
180,
6116-6131.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2007).
Survey of the year 2006 commercial optical biosensor literature.
|
| |
J Mol Recognit,
20,
300-366.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |